Загрузка...
MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells
BACKGROUND: Melanoma is notoriously resistant to all current modalities of cancer therapies including chemotherapy. In recent years, microRNAs (miRNAs) have emerged as molecular regulators in the development and progression of melanoma. However, the relationship between microRNA and chemo-resistance...
Сохранить в:
| Опубликовано в: : | BMC Cancer |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896053/ https://ncbi.nlm.nih.gov/pubmed/29642855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4233-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|